MRNA vs TROX · rev $145.0M vs rev $1.63B
Moderna Inc (MRNA) versus Tronox Holdings PLC (TROX) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Tronox Holdings PLC (TROX) is a chemicals company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported TROX revenue for 2026-06-30 was $1.63B. Net income was -$274.0M. TROX currently screens at market cap $884.2M.
MRNA currently screens at market cap $24.52B. TROX currently screens at market cap $884.2M.
Not investment advice. Open the MRNA and TROX stock pages for the full models.
Not investment advice.